英格兰结缔组织病的发病率和死亡率:2012至2023年人群水平队列研究
该回顾性人群水平研究利用英格兰初级保健记录(临床实践研究数据链),纳入2012至2023年间新诊断结缔组织病的成人患者共22829例(女性占81.1%,中位年龄57岁),描述系统性红斑狼疮、干燥病、系统性硬化症、特发性炎症性肌病和混合性结缔组织病的发病率与全因死亡率趋势。结果显示系统性红斑狼疮和系统性硬化症年龄性别标化发病率下降,特发性炎症性肌病发病率上升,干燥病和混合性结缔组织病相对稳定;特发性炎症性肌病和系统性硬化症队列全因死亡率高。
要点
- 2012至2023年英格兰结缔组织病新诊断共22829例,女性占81.1%,中位年龄57岁。
- 系统性红斑狼疮标化发病率由4.32降至3.29/10万人年,系统性硬化症由2.33降至1.86/10万人年。
- 特发性炎症性肌病标化发病率由3.23升至4.31/10万人年,干燥病和混合性结缔组织病相对稳定。
核心结论
- 研究发现系统性红斑狼疮发病率下降,同时特发性炎症性肌病发病率上升,且特发性炎症性肌病和系统性硬化症队列全因死亡率高。
- 研究认为英格兰结缔组织病疾病谱正在变化,将有助于对该脆弱人群的医疗资源规划。
研究设计与样本
- 回顾性人群水平研究,利用英格兰初级保健记录(临床实践研究数据链),纳入2012至2023年间新诊断结缔组织病的18岁及以上个体。
- 共纳入22829例新诊断结缔组织病病例,女性占81.1%,中位年龄57岁。
- 结局为发病率和全因死亡率,包括年龄标化死亡率、标准化死亡比及使用灵活参数模型评估随时间变化的危险度。
主要发现
- 2012至2023年研究期间,系统性红斑狼疮年龄性别标化发病率由4.32降至3.29/10万人年,系统性硬化症由2.33降至1.86/10万人年。
- 干燥病和混合性结缔组织病发病率保持相对稳定。
- 特发性炎症性肌病诊断由3.23升至4.31/10万人年。
- 研究期间年龄标化死亡率以特发性炎症性肌病最高(27.83/1000人年),其次为系统性硬化症(24.43)、系统性红斑狼疮(16.74)、混合性结缔组织病(16.27),干燥病最低(9.70)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The reported incidence and mortality of connective tissue diseases (CTDs) in England has been inconsistent in the literature. Our objective was to describe current trends in the incidence and mortality of systemic lupus erythematous (SLE), Sjögren's disease (SjD), systemic sclerosis (SSc), idiopathic inflammatory myopathies (IIM) and mixed connective tissue disease (MCTD). METHODS: We conducted a retrospective population-level study using primary care records in England via the Clinical Practice Research Datalink. We included individuals ≥18 years old with new CTD diagnoses between 2012 and 2023. Our outcomes were incidence and all-cause mortality, which included age-standardized mortality rates (ASMRs), standardized mortality ratios and hazards over time using flexible parametric models. RESULTS: There was a total of 22 829 incident CTD diagnoses (81.1% female, median age 57). The age and sex-standardized incidence of SLE and SSc fell over the study period 2012-2023 (SLE: 4.32-3.29 per 100 000 person years [py] and SSc: 2.33-1.86 per 100 000 py), whereas SjD and MCTD incidence remained relatively stable. In contrast, IIM diagnoses rose from 3.23 to 4.31 per 100 000 py. ASMRs across the study period were highest for IIM (27.83 per 1000 py), followed by SSc (24.43), SLE (16.74), MCTD (16.27) and lowest for SjD (9.70). CONCLUSION: Our findings indicated a fall in the incidence of SLE, a simultaneous rise in IIM incidence, and high all-cause mortality within IIM and SSc cohorts. Our study acknowledges the changing landscape of CTDs in England and will aid healthcare resource planning for this vulnerable population.
引用
- Patel S, Russell MD, Bechman K, et al. The incidence and mortality of connective tissue diseases: a population-level cohort study in England from 2012 to 2023. Rheumatology (Oxford). 2025. PMID: 40758464. doi:10.1093/rheumatology/keaf414
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。